Mesenchymal stem cells exert a remarkable regenerative effect requiring minimal CNS integration. Commentary on: "Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function" by Voulgari-Kokota et al.

Experimental Neurology

Volumn 247, Issue , 2013, Pages 292-295

  Uccelli, Antonio ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Advanced Biotechnology Center ABC   (Italy)

Author keywords

Chemokines; Immunomodulation; Mesenchymal stem cells; Microglia; Neuroprotection

Indexed keywords

GLUTAMATE RECEPTOR;

APOPTOSIS; BRAIN NERVE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CULTURE MEDIUM; DOWN REGULATION; EXCITOTOXICITY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; UPREGULATION;

CHEMOKINES; IMMUNOMODULATION; MESENCHYMAL STEM CELLS; MICROGLIA; NEUROPROTECTION;

ANIMALS; FEMALE; KAINIC ACID; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURODEGENERATIVE DISEASES; PREGNANCY;

EID: 84881372270     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.01.028     Document Type: Note

References (42)

1. Bai L., Lennon D.P., Eaton V., Maier K., Caplan A.I., Miller S.D., Miller R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192-1203.
2. Bai L., Lennon D.P., Caplan A.I., Dechant A., Hecker J., Kranso J., Zaremba A., Miller R.H. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 2012, 15:862-870.
3. Carriedo S.G., Yin H.Z., Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996, 16:4069-4079.
4. Chen X., Li Y., Wang L., Katakowski M., Zhang L., Chen J., Xu Y., Gautam S.C., Chopp M. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
5. Constantin G., Marconi S., Rossi B., Angiari S., Calderan L., Anghileri E., Gini B., Bach S.D., Martinello M., Bifari F., Galie M., Turano E., Budui S., Sbarbati A., Krampera M., Bonetti B. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
6. Eliopoulos N., Stagg J., Lejeune L., Pommey S., Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005, 106:4057-4065.
7. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., Uccelli A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 2007, 61:219-227.
8. Giunti D., Parodi B., Usai C., Vergani L., Casazza S., Bruzzone S., Mancardi G., Uccelli A. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 2012, 30:2044-2053.
9. Gordon D., Pavlovska G., Glover C.P., Uney J.B., Wraith D., Scolding N.J. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci. Lett. 2008, 448:71-73.
10. Hong J., Cho I.H., Kwak K.I., Suh E.C., Seo J., Min H.J., Choi S.Y., Kim C.H., Park S.H., Jo E.K., Lee S., Lee K.E., Lee S.J. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 2010, 285:39447-39457.
11. Inoue M., Honmou O., Oka S., Houkin K., Hashi K., Kocsis J.D. Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia 2003, 44:111-118.
12. Isele N.B., Lee H.S., Landshamer S., Straube A., Padovan C.S., Plesnila N., Culmsee C. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochem. Int. 2007, 50:243-250.
13. Jones J., Jaramillo-Merchan J., Bueno C., Pastor D., Viso-Leon M., Martinez S. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol. Dis. 2010, 40:415-423.
14. Jones J., Estirado A., Redondo C., Bueno C., Martinez S. Human adipose stem cell-conditioned medium increases survival of Friedreich's ataxia cells submitted to oxidative stress. Stem Cells Dev. 2012, 21:2817-2826.
15. Kassis I., Grigoriadis N., Gowda-Kurkalli B., Mizrachi-Kol R., Ben-Hur T., Slavin S., Abramsky O., Karussis D. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch. Neurol. 2008, 65:753-761.
16. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., Annunziato F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006, 24:386-398.
17. Lanza C., Morando S., Voci A., Canesi L., Principato M.C., Serpero L.D., Mancardi G., Uccelli A., Vergani L. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J. Neurochem. 2009, 110:1674-1684.
18. Lee J.K., Jin H.K., Bae J.S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci. Lett. 2009, 450:136-141.
19. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
20. Lee H., Lee J.K., Min W.K., Bae J.H., He X., Schuchman E.H., Bae J.S., Jin H.K. Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. Stem Cells 2010, 28:821-831.
21. Lee J.K., Schuchman E.H., Jin H.K., Bae J.S. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid-beta ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 2012, 30:1544-1555.
22. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002, 59:514-523.
23. Morando S., Vigo T., Esposito M., Casazza S., Novi G., Principato M.C., Furlan R., Uccelli A. The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms. Stem Cell Res. Ther. 2012, 3:3.
24. Munoz J.R., Stoutenger B.R., Robinson A.P., Spees J.L., Prockop D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18171-18176.
25. Ohtaki H., Ylostalo J.H., Foraker J.E., Robinson A.P., Reger R.L., Shioda S., Prockop D.J. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14638-14643.
26. Prigione I., Benvenuto F., Bocca P., Battistini L., Uccelli A., Pistoia V. Reciprocal interactions between human mesenchymal stem cells and {gamma}{delta} T cells or invariant natural killer T (iNKT) cells. Stem Cells 2009, 27(3):693-702. (Mar).
27. Prockop D.J. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 2007, 82:241-243.
28. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., Zhao R., Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 2:141-150.
29. Rivera F.J., Couillard-Despres S., Pedre X., Ploetz S., Caioni M., Lois C., Bogdahn U., Aigner L. Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006, 24:2209-2219.
30. Sackstein R., Merzaban J.S., Cain D.W., Dagia N.M., Spencer J.A., Lin C.P., Wohlgemuth R. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. 2008, 14:181-187.
31. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
32. Stemberger C., Dreher S., Tschulik C., Piossek C., Bet J., Yamamoto T.N., Schiemann M., Neuenhahn M., Martin K., Schlapschy M., Skerra A., Schmidt T., Edinger M., Riddell S.R., Germeroth L., Busch D.H. Novel serial positive enrichment technology enables clinical multiparameter cell sorting. PLoS One 2012, 7:e35798.
33. Sutoo D., Akiyama K., Yabe K. A novel technique for quantitative immunohistochemical imaging of various neurochemicals in a multiple-stained brain slice. J. Neurosci. Methods 2002, 118:41-50.
34. Uccelli A., Prockop D.J. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?. Curr. Opin. Immunol. 2010, 22:768-774.
35. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol. 2007, 28:219-226.
36. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8:726-736.
37. Uccelli A., Laroni A., Freedman M.S. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol. 2011, 10:649-656.
38. Uccelli A., Milanese M., Principato M.C., Morando S., Bonifacino T., Vergani L., Giunti D., Voci A., Carminati E., Giribaldi F., Caponnetto C., Bonanno G. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol. Med. 2012, 18:794-804.
39. Voulgari-Kokota A., Fairless R., Karamita M., Kyrargyri V., Tseveleki V., Evangelidou M., Delorme B., Charbord P., Diem R., Probert L. Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp. Neurol. 2012, 236:161-170.
40. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005, 106:1755-1761.
41. Zhang J., Li Y., Lu M., Cui Y., Chen J., Noffsinger L., Elias S.B., Chopp M. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J. Neurosci. Res. 2006, 84:587-595.
42. Zhou C., Zhang C., Chi S., Xu Y., Teng J., Wang H., Song Y., Zhao R. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide. Brain Res. 2009, 1269:23-30.